Pituitary adenylate cyclase acivating peptide (pacap) receptor (vpac2) agonists and their pharmacological methods of use
申请人:Clairmont Kevin
公开号:US20090280106A1
公开(公告)日:2009-11-12
This invention provides peptides with novel modifications that provide suitable derivatization sites to improve the pharmacokinetic properties of the peptides. These modified peptides function in vivo as agonists of the VPAC2 receptor. The peptides of the present invention provide a new therapy for patients with decreased endogenous insulin secretion, for example, type 2 diabetics.
本发明提供了具有新颖修饰的肽,这些修饰提供了适合衍生化的位点,以改善肽的药代动力学特性。这些修饰后的肽在体内作为VPAC2受体的激动剂发挥作用。本发明的肽为具有内源性胰岛素分泌减少的患者,例如2型糖尿病患者提供了新的治疗方法。